Inhibrx Biosciences, Inc.Eigentümerstruktur
| Preis (2026-07-27) | 52W Hoch | 52W Tief |
| 82.45 USD | 155,29 USD | 20,55 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 46,75 USD | 0 | 0 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 14.671.186 | 31,28 | 9,33 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Inhibrx Biosciences, Inc.
Mitarbeiter 109
Handelsplatz NASDAQ
Ticker Symbol INBX
IPO Datum 2024-05-29
Adresse 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Webseite https://inhibrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark Paul Lappe | Founder, CEO & Chairman |
| 2 | Mr. David J. Matly M.B.A. | President |
| 3 | Ms. Kelly Devine Deck B.S., CPA, M.S. | Executive VP, CFO & Treasurer |
| 4 | Ms. Bonne Adams M.B.A. | Vice President of Operations |
| 5 | Ms. Kate Burke CPA, M.B.A. | Vice President of Accounting |
| 6 | Dr. Ashraf Amanullah Ph.D. | Executive VP & Chief Technical Operations Officer |
| 7 | Dr. Carlos Bais Ph.D. | EVP & Chief Scientific Officer |
| 8 | Ms. Leah Pollema J.D. | VP, General Counsel & Corporate Secretary |
| 9 | Dr. Josep Garcia Ph.D. | Executive VP & Chief Clinical Development Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 2 | Viking Global Investors LP | 0,00% | 0,00 Mio. USD |
| 3 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 4 | Sanofi | 0,00% | 0,00 Mio. USD |
| 5 | HighTower Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 6 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Sofinnova Ventures | 0,00% | 0,00 Mio. USD |
| 11 | Capital Research Global Investors | 0,00% | 0,00 Mio. USD |
| 12 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 13 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 14 | Partner Fund Management LP | 0,00% | 0,00 Mio. USD |
| 15 | Schonfeld Strategic Advisors LLC | 0,00% | 0,00 Mio. USD |
| 16 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0,00% | 0,00 Mio. USD |
| 18 | SummitTX Capital, L.P | 0,00% | 0,00 Mio. USD |
| 19 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 20 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |